Zoledronic acid-induced mitochondrial impairment, inflammation, and oxidative stress in the rat kidney

• Autores principales: Heresh Rezaei (Autor), Ayeh Rouhani (Autor), Jale Yüzügülen (Autor), Fatemeh Ghaderi (Autor), Rahil Fazlinezhad (Autor), Mohammad Reza Kiafar (Autor), Zahra Honarpishefard (Autor), Pargol Matinpour (Autor), Abdollah Arjmand (Autor), Negar Azarpira (Autor), Seyed Mohammad Amin Kashani (Autor), Forouzan Khodaei (Autor), Akram Jamshidzadeh (Autor), Reza Heidari (Autor)
• Formato: Libro
• Publicado: Shiraz University of Medical Sciences, 2023-12-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Zoledronic acid (ZLD) is a bisphosphonate drug widely administered against pathological conditions such as hypercalcemia of malignancy, osteoporosis, bone metastases from solid tumors, and multiple myeloma. Unfortunately, renal injury is a serious and dose-limiting adverse effect of ZLD. There is no...